Pharmacotherapy of ADHD in Adults

Rösler, Michael; Retz, Wolfgang; Turner, Daniel

Please use this identifier to cite or link to this item: doi:10.22028/D291-42363

Volltext verfügbar? / Dokumentlieferung

Title:	Pharmacotherapy of ADHD in Adults
Author(s):	Rösler, Michael Retz, Wolfgang Turner, Daniel
Editor(s):	Riederer, Peter Laux, Gerd Nagatsu, Toshiharu Le, Weidong Riederer, Christian
Language:	English
Title:	NeuroPsychopharmacotherapy
Pages:	4543-4560
Publisher/Platform:	Springer Nature
Year of Publication:	2022
DDC notations:	610 Medicine and health
Publikation type:	Book Chapter
Abstract:	Besides psychosocial interventions, like psychoeducation and specific psychotherapeutic treatments, e.g., cognitive-behavioral therapy, pharmacological treatments present a key element within the overall therapeutic concept of attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. Currently, three different pharmacological agents are approved by federal agencies in Germany for the treatment of ADHD in adults. As stimulants, delayed release methylphenidate and lisdexamfetamine can be prescribed. Efficacy and tolerance of both agents can be considered as good. Alternatively, atomoxetine can be prescribed, which does not belong to the stimulants and whose efficacy and tolerance can be considered as good as well.
DOI of the first publication:	10.1007/978-3-030-62059-2_254
URL of the first publication:	https://link.springer.com/referenceworkentry/10.1007/978-3-030-62059-2_254
Link to this record:	urn:nbn:de:bsz:291--ds-423632 hdl:20.500.11880/38027 http://dx.doi.org/10.22028/D291-42363
ISBN:	978-3-030-62058-5 978-3-030-62059-2
Date of registration:	9-Jul-2024
Faculty:	M - Medizinische Fakultät
Department:	M - Forensische Psychologie und Psychiatrie
Professorship:	M - Prof. Dr. Wolfgang Retz
Collections:	SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:

There are no files associated with this item.

Export: BibTex